Sobi® (STO:SOBI) today hosts its Capital Markets Day, where senior management will provide an update on the company’s strategy and outline its new mid-term outlook, aiming to achieve SEK 55bn revenue by 2030, while building…
Category: 6. Business
-

Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
- Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1
- Remibrutinib, a highly selective oral BTK inhibitor, was well-tolerated and demonstrated a favorable safety…
Continue Reading
-

USD valuation drivers: AUD/USD, USD/JPY and USD/CNH outlook
USD/JPY
The BoJ represents the other major central bank on a tightening trajectory. Inflation has exceeded the 2% threshold for 44 consecutive months; nevertheless, the BoJ has proceeded with considerable caution in normalising policy, requiring…
Continue Reading
-
Ericsson and Mastercard enhance global digital money movement and accelerate digital financial inclusion
- Collaboration simplifies access to advanced money movement solutions for telecom service providers, fintechs and banks
- Strengthens digital ecosystems across emerging and…
Continue Reading
-
Ericsson and Mastercard enhance global digital money movement and accelerate digital financial inclusion
- Collaboration simplifies access to advanced money movement solutions for telecom service providers, fintechs and banks
- Strengthens digital ecosystems across emerging and…
Continue Reading
-

MHI Machinery Systems Participates in Ramp Merging Support Demonstration Experiment for Autonomous Vehicles on the Tokyo Metropolitan Expressway– Project Supporting the Establishment of Safe and Convenient Next-Generation Mobility —
Tokyo, February 18, 2026 – Mitsubishi Heavy Industries Machinery Systems, Ltd. (MHI-MS), a part of Mitsubishi Heavy Industries (MHI) Group, has concluded a joint research agreement with Tokyo’s Metropolitan Expressway Co., Ltd. for a…
Continue Reading
-

AIO Trial: Nintedanib Plus Nivolumab in Previously Treated Advanced or Metastatic Lung Cancer
Patients with previously treated metastatic lung adenocarcinoma face a well-recognized therapeutic limitation once platinum-based chemotherapy and immune checkpoint inhibitors (ICIs) have been exhausted.
Beyond these standards,…Continue Reading
-

Asia stocks rise despite lingering AI worries, oil down after U.S-Iran talks
Asian stocks pushed higher on Wednesday despite the renewed artificial intelligence worries gripping international markets, while oil prices were under pressure after Iran touted progress in nuclear negotiations with the United…
Continue Reading
-
Putting Philanthropic Dollars to Work: Future-Building for African Prosperity
As underscored by recent conversations at Davos highlighting Africa’s growing role as a key player in the global economy, 2026 is set to be a critical year for investment across the continent. Yet, amid a complex geopolitical climate and a…
Continue Reading
-

Perplexity drops advertising as it warns it will hurt trust in AI
Stay informed with free updates
Simply sign up to the Artificial intelligence myFT Digest — delivered directly to your inbox.
AI start-up Perplexity has abandoned advertising over fears that it will erode user trust, despite rivals pushing ahead…
Continue Reading
